Oral Calcitonin

被引：0
作者：
Michael J. Maricic
机构：
[1] Catalina Pointe Rheumatology,
来源：
Current Osteoporosis Reports | 2012年 / 10卷
关键词：
Calcitonin; Oral; Osteoporosis; Fracture; Osteoarthritis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Both injectable and nasal spray calcitonins have been utilized in the treatment of postmenopausal osteoporosis for over 25 years. More widespread use of calcitonin in the treatment of osteoporosis has been hampered in part due to poor patient acceptability and compliance and the inability of patients to take this medication as an oral pill. In recent years, an oral preparation of calcitonin has been developed that combines the active peptide hormone with a caprylic acid derivative to enhance bioavailability. Clinical trials with oral calcitonin in patients with osteoarthritis are currently being conducted. A recent phase 3 study failed to demonstrate significant vertebral fracture reduction, and as a result the clinical program for oral calcitonin in osteoporosis is under review for further consideration.
引用
收藏
页码：80 / 85
页数：5
相关论文
共 72 条
  • [1] Copp DH(1961)Demonstration of a hypocalcemic factor (calcitonin) in commercial parathyroid extract Science. 134 2038-8
  • [2] Cameron EC(1995)25 years of salmon calcitonin: from synthesis to therapeutic use [editorial] Calcif Tissue Int 57 405-1485
  • [3] Azria M(2002)Bioavailability and biological efficacy of a new oral formulation of salmon calcitonin in healthy volunteers J Bone Min Res 17 1478-67
  • [4] Copp DH(1999)Treatment with calcitonin suppresses the responses of bone, cartilage, and synovium in the early stages of canine experimental osteoarthritis and significantly reduces the severity of the cartilage lesions Arthritis Rheum 42 1159-430
  • [5] Zanelli JM(2005)Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: a new potential treatment of osteoarthritis Bone 37 425-360
  • [6] Buclin R(1986)Abundant calcitonin receptors in isolate rat osteoclasts, biochemical, and autoradiographic characterization J Clin Invest. 78 355-258
  • [7] Rochat MC(1987)The effect of rectal and nasal administration of salmon calcitonin in normal subjects Calcif Tissue Int. 41 252-11
  • [8] Burckhardt P(2004)Medical management of hypercalcemia Calcif Tissue Int. 74 1-8
  • [9] Manicourt DH(1992)Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture BMJ. 305 1124-349
  • [10] Altman RD(1991)Dose response bioactivity and bioavailability of salmon calcitonin in premenopausal and postmenopausal women J Clin Endocrinol Metab 72 344-76
12345678